Source: International Congress 2018 – Novel insights in the basic and translational research on idiopathic interstitial pneumonias
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Tsitoura (Herakleion, Greece), E. Bibaki (Herakleion, Greece), A. Koutsopoulos (Herakleion, Greece), E. Lagoudaki (Herakleion, Greece), K. Karagianni (Herakleion, Greece), N. Tzanakis (Herakleion, Greece), B. Crestani (Paris, France), K. Antoniou (Herakleion, Greece). Upregulation of Retinoic Acid-Related Orphan Receptor-alpha (RORa) in IPF; a promising therapeutic target. 3713

Member's Comments

No comment yet.

Related content which might interest you: Biosynthesis and implementation of Thyroid Receptor beta (TRß) agonists (thyromimetics) for the treatment of pulmonary fibrosis Source: Virtual Congress 2021 – Genetics and translational aspects of idiopathic pulmonary fibrosis Year: 2021 Neuronal toll-like receptor (TLR) 7 expression and function in human airways Source: International Congress 2014 – Novel approaches to human studies in allergy and asthma Year: 2014 MiR-320d: A novel anti-inflammatory miRNA up regulated by corticosteroids Source: International Congress 2015 – Latest news on miRNAs in pulmonary research Year: 2015 Cytokine-induced glucocorticoid resistance: Effect on GILZ expression and reversal by formoterol Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine Year: 2013 Nuclear miRNA/exosome-mediated transcriptional silencing within the context of TGFB1 signaling and Idiopathic Pulmonary Fibrosis. Source: International Congress 2017 – Interstitial lung diseases (ILDs): novel pathogenetic pathways Year: 2017 Therapeutic potential of CPL-407-105 – Novel potent JAK/STAT pathway inhibitor for the treatment of asthma Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs Year: 2014 Therapeutic blockade of IL-4 and 13 signaling with dupilumab (SAR231893/REGN668) inhibits key biomarkers in asthma Source: Annual Congress 2013 –Treatment of asthma Year: 2013 The anti-inflammatory effects of sulforaphane are not mediated by the Nrf2 pathway Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases Year: 2014 Novel, highly potent and selective JAK3 inhibitor disrupting IL-4/IL-13 signaling in asthma therapy Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD Year: 2015 Maintenance of IRF1 by MAPK inhibition: A mechanism by which DUSP1 reduces glucocorticoid inhibition of CXCL10 Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action Year: 2016 BPI Fold Containing Family A Member 1 (BPIFA1) regulates mucosal microbiota and basal Interferon signaling Source: International Congress 2018 – Disease exacerbations from a molecular point of view Year: 2018 Acute phase protein alpha1-antitrypsin - A novel regulator of angiopoietin-like protein 4 transcription and secretion in human cells Source: International Congress 2014 – Mechanisms of COPD: proteases and a whole lot more Year: 2014 Toll like receptor 4 activation upregulates miR-181b attenuating pulmonary fibrosis via targeting TGFBR1 Source: International Congress 2015 – Latest news on miRNAs in pulmonary research Year: 2015 The Discovery and Development of AZD1402/PRS-060, an Inhaled, Potent and Selective Antagonist of the IL-4 Receptor Alpha Source: International Congress 2018 – Basic pharmacology Year: 2018 LSC - 2017 - Proteasomal Activator 200 (PA200) Regulates Cellular Proliferation: A Putative Role For IPF And Lung Cancer Pathogenesis Source: International Congress 2017 – New insights into pathogenesis of lung disease  Year: 2017 Anti-inflammatory action of Gibberellin in lung epithelial cells is mediated by modification of NF-κB related kinase expression Source: International Congress 2014 – Mechanistic studies of the airway epithelium Year: 2014 The expression of the negative regulator of gene transcription SOCS3 as the crucial marker in the asthma pathogenesis Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases Year: 2014 CCR2, CCR5, their ligands and chemokine receptor-interacting protein FROUNT have impressive effects on pulmonary adenocarcinoma Source: Annual Congress 2013 –Biology and molecular pathology of lung cancer Year: 2013 TLR7 Expression Reveals Novel Bronchodilating Mechanism of Imidazoquinoline Agonists Source: International Congress 2019 – Advances in asthma pharmacology Year: 2019